BX Swiss TOP 30 CHF
1.361,35
PKT
-11,88
PKT
-0,87
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 18.01.19 | UBS Outperform | Credit Suisse Group | |
| 18.01.19 | Novartis Neutral | UBS AG | |
| 18.01.19 | Roche overweight | JP Morgan Chase & Co. | |
| 17.01.19 | UBS buy | UBS AG | |
| 17.01.19 | UBS buy | HSBC | |
| 17.01.19 | UBS neutral | Barclays Capital | |
| 16.01.19 | Novartis Underweight | Barclays Capital | |
| 16.01.19 | Zurich Insurance Neutral | JP Morgan Chase & Co. | |
| 16.01.19 | Swiss Re overweight | Barclays Capital | |
| 16.01.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 15.01.19 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 15.01.19 | Swiss Re buy | Goldman Sachs Group Inc. | |
| 15.01.19 | Swiss Re Sell | UBS AG | |
| 15.01.19 | Swiss Re Sector Perform | RBC Capital Markets | |
| 15.01.19 | Holcim buy | Deutsche Bank AG | |
| 15.01.19 | Nestlé buy | UBS AG | |
| 14.01.19 | ABB (Asea Brown Boveri) Equal-Weight | Morgan Stanley | |
| 14.01.19 | UBS overweight | Morgan Stanley | |
| 14.01.19 | UBS Equal-Weight | Morgan Stanley | |
| 14.01.19 | Nestlé buy | UBS AG | |
| 14.01.19 | Nestlé Underperform | Credit Suisse Group | |
| 14.01.19 | Zurich Insurance Equal weight | Barclays Capital | |
| 11.01.19 | Zurich Insurance Conviction Buy List | Goldman Sachs Group Inc. | |
| 11.01.19 | Roche Hold | Deutsche Bank AG | |
| 11.01.19 | Novartis Hold | Deutsche Bank AG | |
| 10.01.19 | UBS Sector Perform | RBC Capital Markets | |
| 10.01.19 | Holcim overweight | JP Morgan Chase & Co. | |
| 10.01.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 09.01.19 | Swiss Re buy | Kepler Cheuvreux | |
| 09.01.19 | ABB (Asea Brown Boveri) buy | Deutsche Bank AG | |
| 08.01.19 | Zurich Insurance Neutral | JP Morgan Chase & Co. | |
| 08.01.19 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 08.01.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 08.01.19 | ABB (Asea Brown Boveri) buy | Merrill Lynch & Co., Inc. | |
| 07.01.19 | Givaudan Neutral | UBS AG | |
| 07.01.19 | Swiss Re buy | Deutsche Bank AG | |
| 07.01.19 | Zurich Insurance Hold | Deutsche Bank AG | |
| 07.01.19 | UBS overweight | JP Morgan Chase & Co. | |
| 07.01.19 | UBS buy | Merrill Lynch & Co., Inc. | |
| 07.01.19 | UBS buy | Merrill Lynch & Co., Inc. |